Correction to: The Clinical Utility of DCISionRT on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery.
作者信息
Shah Chirag, Bremer Troy, Cox Charles, Whitworth Pat, Patel Rakesh, Patel Anushka, Brown Eric, Gold Linsey, Rock David, Riley Lee, Kesslering Christy, Brown Sheree, Gabordi Robert, Pellicane James, Rabinovich Rachel, Khan Sadia, Templeton Sandra, Majithia Lonika, Willey Shawna C, Wärnberg Fredrik, Gerber Naamit K, Shivers Steve, Vicini Frank A
机构信息
Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
PreludeDx, Laguna Hills, CA, USA.
出版信息
Ann Surg Oncol. 2021 Dec;28(Suppl 3):878. doi: 10.1245/s10434-021-10138-3.
Abstract
摘要
相似文献
1
Correction to: The Clinical Utility of DCISionRT on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery.
Ann Surg Oncol. 2021 Dec;28(Suppl 3):878. doi: 10.1245/s10434-021-10138-3.
2
Cost-Effectiveness Analysis of Biological Signature DCISionRT Use for DCIS Treatment.
Clin Breast Cancer. 2021 Jun;21(3):e271-e278. doi: 10.1016/j.clbc.2020.10.007. Epub 2020 Oct 24.
3
Validation of a Ductal Carcinoma Biomarker Profile for Risk of Recurrence after Breast-Conserving Surgery with and without Radiotherapy.
Clin Cancer Res. 2020 Aug 1;26(15):4054-4063. doi: 10.1158/1078-0432.CCR-19-1152. Epub 2020 Apr 27.
4
Factors associated with residual disease after initial breast-conserving surgery for ductal carcinoma in situ.
Hum Pathol. 2012 Jul;43(7):986-93. doi: 10.1016/j.humpath.2011.09.010. Epub 2012 Jan 4.
5
Cost Effectiveness of DCISionRT for Guiding Treatment of Ductal Carcinoma in Situ.
JNCI Cancer Spectr. 2020 Jan 31;4(2):pkaa004. doi: 10.1093/jncics/pkaa004. eCollection 2020 Apr.
6
Salvage treatment for local recurrence following breast-conserving surgery and definitive irradiation for ductal carcinoma in situ (intraductal carcinoma) of the breast.
Int J Radiat Oncol Biol Phys. 1994 Aug 30;30(1):3-9. doi: 10.1016/0360-3016(94)90512-6.
7
Radiation Therapy Following Breast Conserving Surgery for Ductal Carcinoma in situ: Yes or No?
Chirurgia (Bucur). 2017 Jul-Aug;112(4):403-412. doi: 10.21614/chirurgia.112.4.403.
8
[Ductal carcinoma in situ treated with radiation therapy and additional boost].
Cancer Radiother. 2015 May;19(3):175-9. doi: 10.1016/j.canrad.2015.01.002. Epub 2015 Apr 25.
9
Significance of multifocality in ductal carcinoma in situ: outcomes of women treated with breast-conserving therapy.
J Clin Oncol. 2007 Dec 10;25(35):5591-6. doi: 10.1200/JCO.2007.11.4686. Epub 2007 Nov 5.
10
Long term follow-up of women with ductal carcinoma in situ treated with breast-conserving surgery: the effect of age.
Cancer. 1999 Nov 1;86(9):1757-67. doi: 10.1002/(sici)1097-0142(19991101)86:9<1757::aid-cncr18>3.0.co;2-v.
引用本文的文献
1
Benefits and harms of breast cancer screening revisited: a large, retrospective cross-sectional study quantifying treatment intensity in women with screen-detected versus non-screen-detected cancer in Australia and New Zealand.
BMJ Oncol. 2023 Dec 21;2(1):e000100. doi: 10.1136/bmjonc-2023-000100. eCollection 2023.
2
Analytical validation of the 7-gene biosignature for prediction of recurrence risk and radiation therapy benefit for breast ductal carcinoma .
Front Oncol. 2023 May 19;13:1069059. doi: 10.3389/fonc.2023.1069059. eCollection 2023.
Zotero 插件